SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Pharmalabs - Quaterly Results

28 Oct 2024 Evaluate
The revenue for the September 2024 quarter is pegged at Rs. 3772.94 millions, about 5.94% up against Rs. 3561.43 millions recorded during the year-ago period.Profit saw a slight increase of 14.43%to Rs. 478.37  millions from Rs. 418.06 millions.Operating Profit saw a handsome growth to 877.20 millions from 737.98 millions in the quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 3772.94 3561.43 5.94 7707.80 7142.87 7.91 15021.30 15112.50 -0.60
Other Income 29.47 0.00 0.00 50.60 48.59 4.14 110.10 12.80 760.16
PBIDT 877.20 737.98 18.87 1734.88 1554.01 11.64 3571.60 3096.20 15.35
Interest 53.93 38.16 41.33 96.42 78.50 22.83 166.30 204.90 -18.84
PBDT 823.27 699.82 17.64 1638.46 1475.51 11.04 3405.30 2891.30 17.78
Depreciation 188.93 163.16 15.79 371.86 317.53 17.11 660.10 557.70 18.36
PBT 634.34 536.66 18.20 1266.60 1157.98 9.38 2745.20 2333.60 17.64
TAX 155.97 118.60 31.51 316.79 263.60 20.18 738.70 616.30 19.86
Deferred Tax 28.03 15.00 86.87 73.18 50.00 46.36 278.10 95.00 192.74
PAT 478.37 418.06 14.43 949.81 894.38 6.20 2006.50 1717.30 16.84
Equity 453.13 453.13 0.00 453.13 453.13 0.00 453.10 453.10 0.00
PBIDTM(%) 23.25 20.72 12.20 22.51 21.76 3.46 23.78 20.49 16.05

Aarti Pharmalabs Share Price

699.45 -3.10 (-0.44%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×